| dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
| dc.contributor.author | Cebrià Costa, Joan Pau |
| dc.contributor.author | Gonzalez-Perez, Abel |
| dc.contributor.author | Serra Bardenys, Gemma |
| dc.contributor.author | Querol, J |
| dc.contributor.author | Cosín, M |
| dc.contributor.author | Verde, Gaetano |
| dc.contributor.author | Nuciforo, Paolo Giovanni |
| dc.contributor.author | Rodilla Benito, Verónica |
| dc.contributor.author | Arribas López, Joaquin Vicente |
| dc.contributor.author | Peiro Sales, Sandra |
| dc.contributor.author | Bernadó Morales, Cristina |
| dc.contributor.author | Pascual Reguant, Laura |
| dc.date.accessioned | 2021-11-05T12:47:16Z |
| dc.date.available | 2021-11-05T12:47:16Z |
| dc.date.copyright | 2019 |
| dc.date.issued | 2020-01-02 |
| dc.identifier.citation | Cebrià-Costa JP, Pascual-Reguant L, Gonzalez-Perez A, Serra-Bardenys G, Querol J, Cosín M, et al. LOXL2-mediated H3K4 oxidation reduces chromatin accessibility in triple-negative breast cancer cells. Oncogene. 2020 Jan 2;39(1):79–121. |
| dc.identifier.issn | 1476-5594 |
| dc.identifier.uri | https://hdl.handle.net/11351/6508 |
| dc.description | Cromosomes; Marcadors pronòstics |
| dc.description.sponsorship | This work was supported by grants from Instituto de Salud Carlos III (ISCIII) FIS/FEDER (PI12/01250; CP08/00223; PI16/00253; and CB16/12/00449), MINECO (SAF2013-48849-C2-1-R) to SP, BFU2015-68354 to THS, Breast Cancer Research Foundation (BCRF-17-008) to JA, AGL2014-52395-C2-2-R to DA, Worldwide Cancer Research, Red Temática de Investigación Cooperativa en Cáncer (RD012/0036/005), Fundación Científica de la Asociación Española contra el Cáncer, and Fundació La Marató TV3. THS was supported by institutional funding (MINECO) through the Centres of Excellence Severo Ochoa award and the CERCA Programme of the Catalan Government, and SS-B, by a Fundació La Caixa fellowship. We thank La Caixa Foundation and Cellex Foundation for provide research facilities and equipment. GV has received funding from the MINECO (a “Juan de la Cierva Incorporation” fellowship; IJCI-2014-20723). SP was a recipient of a Miguel Servet contract (ISCIII/FIS), and AI, JPC-C, LP-G, and GS-B are supported by contracts from Worldwide Cancer Research, Fundació La Marató TV3, Fundació FERO, and a FI Fellowship from the Generalitat de Catalunya, respectively. |
| dc.language.iso | eng |
| dc.publisher | Springer Nature |
| dc.relation.ispartofseries | Oncogene;39(1) |
| dc.rights | Attribution 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
| dc.source | Scientia |
| dc.subject | Mama - Càncer - Aspectes genètics |
| dc.subject | Cromatina |
| dc.subject | Regulació genètica |
| dc.subject.mesh | Triple Negative Breast Neoplasms |
| dc.subject.mesh | Chromatin |
| dc.subject.mesh | Gene Expression Regulation, Neoplastic |
| dc.title | LOXL2-mediated H3K4 oxidation reduces chromatin accessibility in triple-negative breast cancer cells |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.1038/s41388-019-0969-1 |
| dc.subject.decs | neoplasias de mama triple negativos |
| dc.subject.decs | cromatina |
| dc.subject.decs | regulación de la expresión génica neoplásica |
| dc.relation.publishversion | https://doi.org/10.1038/s41388-019-0969-1 |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.organismes | Institut Català de la Salut |
| dc.contributor.authoraffiliation | [Cebrià-Costa JP, Pascual-Reguant L, Serra-Bardenys G, Querol J, Cosín M, Nuciforo P, Rodilla V, Peiró S] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Gonzalez-Perez A] Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, 08028 Barcelona, Spain. [Verde G] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. [Bernado-Morales C] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Centro de Investigación Biomédica en Red en Oncología (CIBERONC), 08035 Barcelona, Spain. [Arribas J] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Centro de Investigación Biomédica en Red en Oncología (CIBERONC), 08035 Barcelona, Spain. Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Spain |
| dc.identifier.pmid | 31462706 |
| dc.identifier.wos | 000509849200007 |
| dc.relation.projectid | info:eu-repo/grantAgreement/ES/1PN/2008-2011/PI12%2F01250 |
| dc.relation.projectid | info:eu-repo/grantAgreement/ES/2PN/CP08%2F00223 |
| dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI16%2F00253 |
| dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/CB16%2F12%2F00449 |
| dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/SAF2013-48849-C2-1-R |
| dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/IJCI-2014-20723 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |
